KWS BioTest, a leading contract research organization (CRO) specializing in in vitro and in vivo discovery testing services for immuno-oncology and inflammatory and infectious diseases. The addition of KWS BioTest enhances Charles River’s discovery expertise, with complementary offerings that provide our clients with additional tools in the active therapeutic research areas of oncology and immunology.

Authors

Professor Neil A. Williams

Professor Neil A. Williams, CSO at KWS BioTest, commented: “The recognition that some conventional and new cancer therapies can enhance recognition of cancer cells by the immune system points toward...

❮ ❯

Articles

2925

Cancer drug screening process saves discovery time...